Artificial intelligence and life sciences, do they go together? The almost unlimited possibilities of AI are offset by previously uncontrolled risks.
As is often the case with new technologies, more space is given to possibilities rather than to risks. So it is not surprising that in the field of AI software applications, the negative statements about possible applications in the life science field are increasing. Can the seductive possibilities and the necessary controls be brought together? How can you do both?
The webinar ‘Artificial Intelligence in the Life Science and Pharmaceutical Industry’ on Friday, November 6th, 2020 starting at 9:00 am we will provide answers to these questions. What solutions are in sight and what conclusions can be drawn from them?
Ingo Baumann from Thescon gives you an insight into the status of the discussion and suggestions for adapting established CSV and quality frameworks in the course of AI development.
Dr. Jörg Stüben from Boehringer Ingelheim uses practical examples to illustrate the use of AI in the regulated pharmaceutical environment.
Klaus Eichmüller from the Darmstadt Regional Council investigates the question of whether one can proceed according to the rules of classic computer system validation when testing the AI?
Based on the lectures, an intensive discussion between the participants and experts will be made possible at this webinar. Ideas and your own approaches can be discussed and further developed with experts and industry colleagues.
Registrations are accepted on the PTS Training Service website here.
We look forward to your participation!
Your Thescon team.